Two self-insured employers ran their PBM contracts through this checklist. One cut pharmacy spend 47% ($484,000 in year one). The other generated $500,000+ in first-year savings, with employee out-of-pocket costs down 23% by 18 months. Get the questions, the answers to watch for, and the five contract terms that may signal you’re overpaying.
Free. No obligation. No medical-plan or broker change required. Work email only.
Written by Eric Papp. As presented at SHRM’s 2026 national conference.
Figures are from two client engagements. Results vary by plan, contract terms, and utilization.
The 12 questions are only the starting point. This executive guide shows you what to look for, how to interpret your PBM’s answers, and what to do before your renewal window closes.
Inside the Playbook:
By the end, you’ll know:
Free for self-insured employers with 200 to 2,000 employees. No obligation.
We audited the contracts behind both case studies. Different PBMs, different employer sizes, same three terms: the PBM keeps the manufacturer rebates, spread pricing is allowed, and there is a financial penalty for leaving early. None of it is illegal. The question for a plan fiduciary is simply: who does this benefit?
Largest PBM by prescription volume
Part of Cigna — second largest PBM
UnitedHealth Group subsidiary
200-employee national law firm. Spread pricing on 60% of generic claims, a rebate guarantee covering only 71% of eligible claims, and no audit rights. In year one: $484,000 saved, a 47% reduction, with about 3% of members affected.
1,500-employee hospitality group. The carve-out generated $500,000+ in first-year savings. By 18 months, employee out-of-pocket costs were down 23%, with only about 3% of members experiencing a medication change.
of U.S. prescriptions are managed by the three largest PBMs, leaving most employers with limited negotiating leverage and little visibility into true costs. Source: FTC interim staff report on pharmacy benefit managers, July 2024.
PBM compensation structures can reward volume and rebate capture rather than lowering your organization's net drug cost.
PBM contracts are often structured in ways that obscure the relationship between reported savings and actual spend changes.
When reporting centers on discounts and rebates rather than total cost trend, it becomes difficult to assess whether the plan is truly performing.
In some arrangements, PBMs charge employers more than they reimburse pharmacies — capturing the difference as undisclosed revenue.
Without active specialty management strategies, employers may face significant and unexpected cost increases driven by a small number of high-cost prescriptions.
Formularies that aren't actively managed may allow higher-cost branded drugs to be dispensed when clinically equivalent generics are available.
High-performing employers are taking a closer look at pharmacy and asking whether a more transparent model can deliver better alignment, greater control, and lower net cost.
A transparent pharmacy carve-out can help employers move away from opaque pricing structures and toward a model where incentives are aligned around reducing actual spend, not just producing favorable-looking reports.
Eric Papp presenting "The Hidden Cost of Pharmacy Benefits" at the SHRM Annual Conference, June 2026.
See exactly what you're paying — ingredient cost, dispensing fees, and any margins — with no hidden spread pricing.
Work with a PBM model where success is measured by actual cost reduction — not rebate volume or network spread.
Own your own formulary and clinical programs — making decisions based on your population's needs, not the PBM's book of business.
The goal of a transparent carve-out is measurable, sustainable reduction in what you actually spend on pharmacy — not just better-looking reports.
Pharmacy Benefits Unbundled is an educational resource from Eric Papp, a Tampa-based employee benefits consultant who works with self-insured employers with 200 to 2,000 employees.
His work centers on a question most plans have never asked out loud: what does the pharmacy benefit actually cost once you separate it from the medical plan? Eric is the author of Leadership by Choice (Wiley) and Manage Promises, Not People, and spoke on pharmacy carve-outs at SHRM’s 2026 national conference. Eric is a graduate of the University of Notre Dame.
"We work for you, not the carriers."
What You Can Expect:
What we are paid for pharmacy work comes from the employer and is disclosed to you. The PBM pays us nothing, so the only thing the recommendation can be about is your net cost.
Our team has experience evaluating PBM contracts, carve-out structures, and specialty drug management strategies across a wide range of employer sizes and industries.
We focus on clear analysis and concrete steps — not abstract frameworks or long consulting engagements that delay real decisions.
The 12 questions and the Executive Pharmacy Review work alongside your current broker and carrier. Nothing has to change for you to see what your PBM contract actually costs.
The copy-and-paste email, plus the 27-page Playbook that shows you what the answers mean. Forward the questions to your PBM tomorrow morning. No commitment in asking.
Questions about your PBM contract, or want a second set of eyes on the answers you get back? Email Eric directly. Replies come from him, not a sales team.
epapp@mewilson.com
Pharmacy Benefits Unbundled collects only what you enter in the form: your name and work email. We use them to send The Pharmacy Carve-Out Playbook and occasional emails about pharmacy benefits. You can unsubscribe from any email with one click. We do not sell or share your information. Standard website analytics count visits. Questions: epapp@mewilson.com.
This page is for general information only and is not legal, tax, or financial advice. Savings figures come from client engagements; results vary by plan, contract terms, and utilization.